National Pharmaceutical Council Appoints John M. O'Brien as President and CEO
Share this article Share this article WASHINGTON, April 2, 2021 /PRNewswire/ -- The National Pharmaceutical Council (NPC), a health policy research organization dedicated to the advancement of evidence, science and medical innovation, today announced the appointment of veteran drug pricing and health policy expert John M. O'Brien, Pharm.D., MPH, as president and chief executive officer. O'Brien, who will assume the role on June 1, will be responsible for overseeing NPC's policy research and communications capacity, partnerships with other health care organizations, and strategic vision. The ...